LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

UroGen Pharma Ltd.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERURGN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / URGN COVERAGE

What’s moving UroGen Pharma Ltd. now

Current reporting with the operating signal separated from the noise.

01
TradingKey

Urogen Pharma Ltd (URGN) Risk Assessment: Volatility, Financial Risk & Investment Risk

The story matters when it changes UroGen Pharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
UroGen Pharma Ltd. (URGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

UroGen Pharma Ltd. (URGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

The story matters when it changes UroGen Pharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
UroGen Pharma Ltd. (URGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

UroGen Pharma Ltd. (URGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

The story matters when it changes UroGen Pharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Law Offices of Howard G. Smith Encourages UroGen Pharma Ltd. (URGN) Investors To Inquire About Securities Fraud Class Action

Law Offices of Howard G. Smith Encourages UroGen Pharma Ltd. (URGN) Investors To Inquire About Securities Fraud Class Action

The story matters when it changes UroGen Pharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest URGN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-06 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-02 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-23 · Period 2026-06-22SEC ↗8-KMaterial company eventFiled 2026-06-02 · Period 2026-06-02SEC ↗8-KMaterial company eventFiled 2026-05-06 · Period 2026-05-06SEC ↗6-KOfficial SEC filingFiled 2018-11-13 · Period 2018-09-30SEC ↗6-KOfficial SEC filingFiled 2018-10-31 · Period 2018-10-31SEC ↗
EARNINGS / QUARTERLY TRACKER

UroGen Pharma Ltd., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.